No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
www.ebosgroup.comNo one on the platform currently holds EBO.AX.
No tracked institution reports a position in EBO.AX as of their last filing.
No one on the platform has traded EBO.AX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 6.2% | 7.7% | 9.9% | — | — | — |
| Rev. Growth % | 5.1% | 6.8% | ||||
| Profit Margin % | 1.7% | 1.9% | 1.9% | |||
| Free Cash Flow Margin % | 1.6% | 2.1% | 1.9% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $17.0B | +3.4% | $1.44 | $1.43–$1.45 | — | 4 |
| 2028 | $17.7B | +4.0% | $1.61 | $1.57–$1.69 | — | 4 |
| 2029 | $18.4B | +3.9% | $1.79 | $1.74–$1.82 | — | 1 |
| 2030 | $18.7B | +1.7% | $1.74 | $1.69–$1.78 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-18 | $0.59 | $0.60 | +1.3% |
| 2026-02-24 | $0.61 | $0.61 | +0.0% |
| 2025-08-26 | $0.66 | $0.49 | -25.6% |
| 2025-02-18 | $0.71 | $0.68 | -4.8% |
| 2024-08-21 | $0.77 | $0.78 | +2.3% |
| 2024-02-20 | $0.76 | $0.80 | +4.3% |
| 2023-08-22 | $0.69 | $0.73 | +6.8% |
| 2023-02-21 | $0.74 |
| $0.74 |
| +0.7% |
| -2.85% |
| $2.6B |
| — |
| OCA.AXOceania Healthcare Limited | $0.57 | -4.17% | $416M | — |
| PGC.AXParagon Care Limited | $0.14 | +3.85% | $223M | — |
Source: Financial Modeling Prep · peers by sector/industry